Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis.

MLA

Di Franco, R., et al. “Rectal/Urinary Toxicity after Hypofractionated vs. Conventional Radiotherapy in High Risk Prostate Cancer: Systematic Review and Meta Analysis.” European Review for Medical & Pharmacological Sciences, vol. 21, no. 16, Aug. 2017, pp. 3563–75. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=124925791&authtype=sso&custid=ns315887.

APA

Di Franco, R., Borzillo, V., Ravo, V., Ametrano, G., Cammarota, F., Rossetti, S., Romano, F. J., D’aniello, C., Cavaliere, C., Iovane, G., Porricelli, M. A., Muto, M., Berretta, M., Facchini, G., & Muto, P. (2017). Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis. European Review for Medical & Pharmacological Sciences, 21(16), 3563–3575.

Chicago

Di Franco, R., V. Borzillo, V. Ravo, G. Ametrano, F. Cammarota, S. Rossetti, F. J. Romano, et al. 2017. “Rectal/Urinary Toxicity after Hypofractionated vs. Conventional Radiotherapy in High Risk Prostate Cancer: Systematic Review and Meta Analysis.” European Review for Medical & Pharmacological Sciences 21 (16): 3563–75. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=124925791&authtype=sso&custid=ns315887.